UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 653

Sortiert nach

Manganese- and Platinum-Driven Oxidative and Nitrosative Stress in Oxaliplatin-Associated CIPN with Special Reference to Ca4Mn(DPDP)5, MnDPDP and DPDP

International journal of molecular sciences, 2024-04, Vol.25 (8), p.4347

2024

Volltextzugriff (PDF)

Evidence that fodipir (DPDP) binds neurotoxic Pt2+ with a high affinity: An electron paramagnetic resonance study

Scientific reports, 2019-11, Vol.9 (1), Article 15813

2019

Volltextzugriff (PDF)

Is it possible to draw firm conclusions from the PLIANT trial?

Acta oncologica, 2018-06, Vol.57 (6), p.862-864

2018

Volltextzugriff (PDF)

May Mangafodipir or Other SOD Mimetics Contribute to Better Care in COVID-19 Patients?

Antioxidants, 2020-10, Vol.9 (10), p.971

2020

Volltextzugriff (PDF)

Mangafodipir a Selective Cytoprotectant — with Special Reference to Oxaliplatin and Its Association to Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Translational oncology, 2017-08, Vol.10 (4), p.641-649

2017

Volltextzugriff (PDF)

Comments on “Clinically relevant therapeutic approaches against acetaminophen (APAP) hepatotoxicity and acute liver failure”

Biochemical pharmacology, 2024-07, Vol.225, p.116276, Article 116276

2024

Volltextzugriff (PDF)

Exacerbated Neuropathy in POLAR A and M Trials Due to Redox Interaction of PledOx-Associated Mn2+ and Oxaliplatin-Associated Pt2

Antioxidants, 2023-03, Vol.12 (3), p.608

2023

Volltextzugriff (PDF)

Manganese- and Platinum-Driven Oxidative and Nitrosative Stress in Oxaliplatin-Associated CIPN with Special Reference to Ca 4 Mn(DPDP) 5 , MnDPDP and DPDP

International journal of molecular sciences, 2024-04, Vol.25 (8)

2024

Volltextzugriff (PDF)

The Damaging Outcome of the POLAR Phase III Trials Was Due to Avoidable Time-Dependent Redox Interaction between Oxaliplatin and PledOx

Antioxidants, 2021-12, Vol.10 (12), p.1937

2021

Volltextzugriff (PDF)

Repeated transient sulforaphane stimulation in astrocytes leads to prolonged Nrf2-mediated gene expression and protection from superoxide-induced damage

Neuropharmacology, 2011-02, Vol.60 (2-3), p.343-353

2011

Volltextzugriff (PDF)

N-acetylcysteine reduces lipopolysaccharide-sensitized hypoxic-ischemic brain injury

Annals of neurology, 2007-03, Vol.61 (3), p.263-271

2007

Volltextzugriff (PDF)

Letter in response to: "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial"

Trials, 2019-06, Vol.20 (1), p.380-380, Article 380

2019

Volltextzugriff (PDF)

Comment on “Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity” Antioxidants 2020, 9, 594

Antioxidants, 2020-09, Vol.9 (9), p.802

2020

Volltextzugriff (PDF)

Kinetic studies of small molecule interactions with protein kinases using biosensor technology

Analytical biochemistry, 2005-05, Vol.340 (2), p.359-368

2005

Volltextzugriff (PDF)

Studies of small molecule interactions with protein phosphatases using biosensor technology

Analytical biochemistry, 2006-06, Vol.353 (2), p.217-225

2006

Volltextzugriff (PDF)

Flow-Mediated On-Surface Reconstitution of G-Protein Coupled Receptors for Applications in Surface Plasmon Resonance Biosensors

Analytical biochemistry, 2002-01, Vol.300 (2), p.132-138

2002

Volltextzugriff (PDF)

Post-cardioversion Improvement in LV Function Defined by 4D Flow Patterns and Energetics in Patients With Atrial Fibrillation

Frontiers in physiology, 2019-05, Vol.10, p.659-659

2019

Volltextzugriff (PDF)

First Clinical Experience with the Magnetic Resonance Imaging Contrast Agent and Superoxide Dismutase Mimetic Mangafodipir as an Adjunct in Cancer Chemotherapy—A Translational Study

Translational oncology, 2012-02, Vol.5 (1), p.32-38

2012

Volltextzugriff (PDF)

Evidence that fodipir (DPDP) binds neurotoxic Pt 2+ with a high affinity: An electron paramagnetic resonance study

Scientific reports, 2019-11, Vol.9 (1), p.15813

2019

Volltextzugriff (PDF)

Superior Therapeutic Index of Calmangafodipir in Comparison to Mangafodipir as a Chemotherapy Adjunct

Translational oncology, 2012-12, Vol.5 (6), p.492-502

2012

Volltextzugriff (PDF)

Exacerbated Neuropathy in POLAR A and M Trials Due to Redox Interaction of PledOx-Associated Mn[sup.2+] and Oxaliplatin-Associated Pt[sup.2+]

Antioxidants, 2023-03, Vol.12 (3)

2023

Volltextzugriff (PDF)

Nuclear translocation and calpain-dependent reduction of Bcl-2 after neonatal cerebral hypoxia–ischemia

Brain, behavior, and immunity, 2010-07, Vol.24 (5), p.822-830

2010

Volltextzugriff (PDF)

Letter in response to: "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdosethe PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial"

Trials, 2019-06, Vol.20

2019

Volltextzugriff (PDF)

Cyclosporin A prevents calpain activation despite increased intracellular calcium concentrations, as well as translocation of apoptosis‐inducing factor, cytochrome c and caspase‐3 activation in neurons exposed to transient hypoglycemia

Journal of neurochemistry, 2003-06, Vol.85 (6), p.1431-1442

2003

Volltextzugriff (PDF)

Mindfulness-Based Stress Reduction (MBSR) Delivered Live on the Internet to Individuals Suffering from Mental Fatigue After an Acquired Brain Injury

Mindfulness, 2015-12, Vol.6 (6), p.1356-1365

2015

Volltextzugriff (PDF)

1 – 25 von 653

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(568)
Mit Volltextzugriff
(604)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(431)
Life Sciences & Biomedicine
(333)
Humans
(213)
Female
(166)
Male
(155)
Biological And Medical Sciences
(141)
Medicin Och Hälsovetenskap
(106)
Physical Sciences
(97)
Medical Sciences
(96)
Animals
(89)
Middle Aged
(82)
Adult
(79)
Aged
(75)
Physics
(63)
Technology
(63)
Medical And Health Sciences
(61)
Orthopedics
(61)
Fundamental And Applied Biological Sciences. Psychology
(49)
Clinical Medicine
(48)
Klinisk Medicin
(46)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Manganese- and Platinum-Driven Oxidative and Nitrosative Stress in Oxaliplatin-Associated CIPN with Special Reference to Ca4Mn(DPDP)5, MnDPDP and DPDP

Evidence that fodipir (DPDP) binds neurotoxic Pt2+ with a high affinity: An electron paramagnetic resonance study

Is it possible to draw firm conclusions from the PLIANT trial?

May Mangafodipir or Other SOD Mimetics Contribute to Better Care in COVID-19 Patients?

Mangafodipir a Selective Cytoprotectant — with Special Reference to Oxaliplatin and Its Association to Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Comments on “Clinically relevant therapeutic approaches against acetaminophen (APAP) hepatotoxicity and acute liver failure”

Exacerbated Neuropathy in POLAR A and M Trials Due to Redox Interaction of PledOx-Associated Mn2+ and Oxaliplatin-Associated Pt2

Manganese- and Platinum-Driven Oxidative and Nitrosative Stress in Oxaliplatin-Associated CIPN with Special Reference to Ca 4 Mn(DPDP) 5 , MnDPDP and DPDP

The Damaging Outcome of the POLAR Phase III Trials Was Due to Avoidable Time-Dependent Redox Interaction between Oxaliplatin and PledOx

Repeated transient sulforaphane stimulation in astrocytes leads to prolonged Nrf2-mediated gene expression and protection from superoxide-induced damage

N-acetylcysteine reduces lipopolysaccharide-sensitized hypoxic-ischemic brain injury

Letter in response to: "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial"

Comment on “Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity” Antioxidants 2020, 9, 594

Kinetic studies of small molecule interactions with protein kinases using biosensor technology

Studies of small molecule interactions with protein phosphatases using biosensor technology

Flow-Mediated On-Surface Reconstitution of G-Protein Coupled Receptors for Applications in Surface Plasmon Resonance Biosensors

Post-cardioversion Improvement in LV Function Defined by 4D Flow Patterns and Energetics in Patients With Atrial Fibrillation

First Clinical Experience with the Magnetic Resonance Imaging Contrast Agent and Superoxide Dismutase Mimetic Mangafodipir as an Adjunct in Cancer Chemotherapy—A Translational Study

Evidence that fodipir (DPDP) binds neurotoxic Pt 2+ with a high affinity: An electron paramagnetic resonance study

Superior Therapeutic Index of Calmangafodipir in Comparison to Mangafodipir as a Chemotherapy Adjunct

Exacerbated Neuropathy in POLAR A and M Trials Due to Redox Interaction of PledOx-Associated Mn[sup.2+] and Oxaliplatin-Associated Pt[sup.2+]

Nuclear translocation and calpain-dependent reduction of Bcl-2 after neonatal cerebral hypoxia–ischemia

Letter in response to: "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdosethe PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial"

Cyclosporin A prevents calpain activation despite increased intracellular calcium concentrations, as well as translocation of apoptosis‐inducing factor, cytochrome c and caspase‐3 activation in neurons exposed to transient hypoglycemia

Mindfulness-Based Stress Reduction (MBSR) Delivered Live on the Internet to Individuals Suffering from Mental Fatigue After an Acquired Brain Injury

Suchergebnisse filtern